Condition
Viral Respiratory Tract Infection
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed3
Not Yet Recruiting1
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07279298Not Yet Recruiting
Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV
NCT05290792Not ApplicableCompletedPrimary
Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections
NCT06248983Completed
Transmission Of Respiratory Tract microOrganisms In a School Environment
NCT05093530Phase 1CompletedPrimary
Safety and Tolerability of Single and Multiple Doses of Neumifil
NCT04815018Terminated
Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2
NCT02640066Not ApplicableUnknownPrimary
Acupuncture for Acute Viral Lower Respiratory Infection in Hospitalized Children
Showing all 6 trials